YKP-1358 Uses, Dosage, Side Effects and more
YKP1358 is a novel serotonin (5-HT2A) and dopamine (D2) antagonist that has demonstrated potent activity in animals that relates to both positive and negative symptoms of schizophrenia. In addition, the YKP1358 pharmacological profile suggests a very low potential for extrapyramidal side effects.
| Trade Name | YKP-1358 |
| Generic | YKP-1358 |
| Type | |
| Groups | Investigational |
| Therapeutic Class | |
| Manufacturer | |
| Available Country | |
| Last Updated: | January 7, 2025 at 1:49 am |
Uses
Investigated for use/treatment in schizophrenia and schizoaffective disorders.
How YKP-1358 works
serotonin (5-HT2A) and dopamine (D2) antagonist.
